Read the Latest News

And the Committee heard from the American Association of Oral and Maxillofacial Surgeons

At the end of the NAM meeting, Dr. Gregory Ness, representing the American Association of Oral and Maxillofacial Surgeons (AAMOS) gave the following comments: “AAMOS welcomes the interest and support of the Academies, the NIH, NIDCR, FDA and The

What Allen Told the Committee

Allen Cowley addressed the second open-to-the-public meeting of the National Institute of Medicine's (NAM) Committee on Temporomandibular Disorders (TMD) held on March 28, 2019 in Washington, DC. No stranger to the world of TMD, Dr. Cowley is the hus

Some Thoughts on Depression

It is hardly surprising that the chronic pain and limitations in function that many long-time TMJ patients experience can be accompanied by a state of depression, a sense of exhaustion and hopelessness.

Upcoming NAM Public Webinars on TMD

The National Academy of Medicine's (NAM) Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment is hosting two public web conferences on Wednesday, June 19 and Wednesday, July 31.   Webinar 1: Pati

The NAM Committee Heard from Patients, Too

At the March 28, 2019 public meeting NAM committee members had a chance to hear from TMD patients who had submitted testimony for the record.

National Academy of Medicine Holds Second TMD Meeting

  • Apr 25, 2019

We have reported prevsioulsy about the decision of the prestigious National Academy of Medicine (NAM) to convene a committee of experts to examine all aspects of temporomandibular disorders (TMD). Terrie Cowley, The TMJ Association (TMJA) President, spoke at the initial meeting open to the public, and she and others from the TMJA attended a second 2-day meeting, also open to the public, held on March 28-29, 2019, in Washington, DC. Stakeholders from the patient, caregiver, and research communities as well as representatives of federal agencies, insurers, and manufacturers were invited to provide their perspectives.  

The agenda was organized into five panels: TMD scope and definition; public health burden; basic and preclinical research; clinical and translational research; and care pathways. Each panel included testimony from a TMJ patient, as well as speakers addressing the panel theme, with a discussion period following the presentations. Each day concluded with a public comment period with attendees given 3-5 minutes to share their perspectives with the Committee.

For a you-are-there experience we invite you to view the online video recording of the meeting, along with the presenters' slides:

Importantly, if you were not able to participate in the public comment period, you are able to share your valuable perspectives on your TMJ experience with the Committee in writing to They are grateful for patient input to the study. The NAM committee will continue to meet throughout 2019. The committee's recommendations and the study findings will be summarized in a final report in the spring of 2020.

The third meeting of the NAM TMD Committee will be closed to the public and will convene on May 1-2, 2019. 

The TMJ Association by Terrie Cowley


Login or Register to add Comment